Shearman & Sterling’s Healthcare Industry Group leaders Mark Kessel and Robert Masella contributed a chapter to the recently released Healthcare Mergers & Acquisitions Answer Book published by Practising Law Institute. Kessel and Masella’s chapter, titled “Financing Drug Development,” examines historical patterns of financing as well as newer alternatives. It also discusses the increasing collaboration between big pharma and smaller biotech companies in the development of new drugs.

View full chapter, Financing Drug Development.